Metformin lowers blood sugar through several overlapping mechanisms, primarily by reducing the amount of glucose your liver releases and helping your muscles absorb sugar more effectively. At maximum doses, it typically lowers A1c levels by as much as 1.5%, which is why it remains the first medication prescribed for most people with type 2 diabetes.
Reducing Sugar Output From the Liver
Your liver constantly produces glucose to keep your blood sugar stable between meals. In type 2 diabetes, this process goes into overdrive, pumping out glucose even when blood sugar is already high. Metformin’s primary job is dialing this back. It interferes with a specific step in your cells’ energy production chain (part of the mitochondria), which shifts the chemical signals your liver uses to decide how much sugar to make. The net effect is that your liver releases less glucose into your bloodstream, especially overnight and between meals, when fasting blood sugar tends to climb.
Helping Muscles Use Glucose
Skeletal muscle is the biggest consumer of blood sugar in your body, and metformin makes that tissue more responsive to insulin. It does this largely by activating an energy-sensing enzyme called AMPK, which acts like a fuel gauge inside your cells. When AMPK switches on, it triggers a chain of events that moves more glucose transporters (called GLUT4) to the surface of muscle cells. Think of GLUT4 as a door that lets sugar pass from the bloodstream into the cell. Metformin both increases the number of these doors and keeps them open longer.
On top of that, metformin enhances the signaling cascade that insulin itself uses. It boosts the activity of insulin receptors on cell surfaces and supports the internal relay system that tells cells to pull in glucose. This means the insulin your body already produces works more efficiently, so your pancreas doesn’t have to compensate by producing ever-larger amounts.
Effects in the Gut
A growing body of evidence shows that metformin also works inside the intestine. It shifts the composition of bacteria in the upper small intestine, notably increasing the abundance of beneficial Lactobacillus species. This microbial shift restores a glucose-sensing pathway involving a transporter called SGLT1, which helps the gut detect incoming sugar and coordinate an appropriate hormonal response. When researchers transplanted gut bacteria from metformin-treated animals into untreated ones, the recipients gained improved glucose sensing as well, confirming the microbiome plays an active role in the drug’s effects.
Part of the reason metformin causes digestive side effects like nausea, bloating, and diarrhea is precisely because so much of the drug accumulates in intestinal tissue. These side effects are most common when you first start taking it and typically ease as your body adjusts.
How It’s Typically Started
Metformin is introduced gradually to minimize stomach trouble. A common schedule looks like this:
- Week 1: One 500 mg tablet with or after breakfast
- Week 2: One 500 mg tablet with breakfast and one with your evening meal
- Week 3 onward: One 500 mg tablet with breakfast, lunch, and dinner, building toward a maximum of 2,000 mg per day
Taking it with food makes a noticeable difference in how well you tolerate it. An extended-release version is also available, which releases the drug more slowly and often causes fewer gastrointestinal symptoms.
Cardiovascular Benefits
Metformin has been in clinical use for over 60 years, and that long track record includes consistent evidence of heart protection. Both randomized trials and large real-world studies have shown that people with type 2 diabetes who take metformin have a lower risk of cardiovascular events compared to some other glucose-lowering treatments. Heart failure is now recognized as the most common complication of diabetes, and research has focused on metformin’s potentially protective effects in this area as well. These cardiovascular benefits are one reason metformin remains a cornerstone of diabetes treatment even as newer drug classes have emerged.
Vitamin B12 and Long-Term Use
One side effect that doesn’t get enough attention is vitamin B12 depletion. Updated product information now lists B12 deficiency as a common adverse reaction, potentially affecting up to 1 in 10 people who take metformin. The risk increases with higher doses and longer treatment duration. Low B12 can cause fatigue, numbness or tingling in the hands and feet, and a type of anemia that may be mistaken for other conditions. If you’ve been on metformin for several years, periodic B12 monitoring is worth discussing, especially if you notice neurological symptoms like tingling or difficulty with balance.
Kidney Function and Dose Limits
Metformin is cleared through the kidneys, so how well your kidneys work determines whether you can take it safely. The key measure is your estimated glomerular filtration rate, or eGFR, a number you’ll find on routine blood work. Above 45, metformin is considered safe for most people. Between 30 and 45, the dose needs to be reduced. Below 30, or for anyone on dialysis, metformin should be stopped. Your eGFR is checked regularly as part of standard diabetes care, so adjustments happen before problems arise.
Why It Remains the First Choice
Metformin’s combination of effectiveness, safety profile, low cost, and decades of real-world data is difficult to match. It lowers blood sugar without causing the weight gain associated with some other diabetes medications, and it rarely causes dangerously low blood sugar on its own. Its effects on the liver, muscles, and gut work together to address multiple aspects of insulin resistance simultaneously rather than targeting a single pathway. For the vast majority of people newly diagnosed with type 2 diabetes, it is the starting point of treatment, and many continue taking it even when additional medications are added later.